{"transactions":[{"id":3118447,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":148623,"kind":"person","name":"Oliva Adele C","position":1,"cik":"0001339379","reported_name":"Oliva Adele C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-08T16:38:42.000Z","date":"2020-06-04","kind":"grant","acquired":true,"shares":8806,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of (a) the first anniversary of June 4, 2020, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's 2019 Equity Incentive Plan), subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":8806,"derivative":{"exercise_price":17,"expiration_date":"2030-06-04","underlying":"Common Stock","underlying_shares":8806},"source":{"system":"sec-edgar","filing":"0001192482-20-000450","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339379/000119248220000450/edgar.xml","form_type":"4"}},{"id":3372631,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":148623,"kind":"person","name":"Oliva Adele C","position":1,"cik":"0001339379","reported_name":"Oliva Adele C","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2019-11-13T20:48:29.000Z","date":"2019-11-13","kind":"exercise","acquired":true,"shares":446813,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Quaker Bioventures II, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Warrants exercisable for shares of Series B Preferred Stock automatically converted into warrants exercisable for shares of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for the purposes of Section 16 or otherwise."}],"balance_after":446813,"derivative":{"exercise_price":28.65,"exercise_date":"2019-11-13","expiration_date":"2027-01-18","underlying":"Common Stock","underlying_shares":18096},"source":{"system":"sec-edgar","filing":"0001192482-19-000420","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1339379/000119248219000420/edgar.xml","form_type":"4"}},{"id":3372630,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":148623,"kind":"person","name":"Oliva Adele C","position":1,"cik":"0001339379","reported_name":"Oliva Adele C","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2019-11-13T20:48:29.000Z","date":"2019-11-13","kind":"exercise","acquired":false,"shares":446813,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Quaker Bioventures II, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Warrants exercisable for shares of Series B Preferred Stock automatically converted into warrants exercisable for shares of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for the purposes of Section 16 or otherwise."}],"balance_after":0,"derivative":{"exercise_price":1.16,"exercise_date":"2017-01-18","expiration_date":"2027-01-18","underlying":"Series B Preferred Stock","underlying_shares":446813},"source":{"system":"sec-edgar","filing":"0001192482-19-000420","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1339379/000119248219000420/edgar.xml","form_type":"4"}},{"id":3372629,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":148623,"kind":"person","name":"Oliva Adele C","position":1,"cik":"0001339379","reported_name":"Oliva Adele C","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2019-11-13T20:48:29.000Z","date":"2019-11-13","kind":"exercise","acquired":false,"shares":12763434,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Quaker Bioventures II, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"Reflects 1-for-24.69 reverse stock split which became effective on October 28, 2019."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for the purposes of Section 16 or otherwise."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":516947},"source":{"system":"sec-edgar","filing":"0001192482-19-000420","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1339379/000119248219000420/edgar.xml","form_type":"4"}},{"id":3372628,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":148623,"kind":"person","name":"Oliva Adele C","position":1,"cik":"0001339379","reported_name":"Oliva Adele C","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2019-11-13T20:48:29.000Z","date":"2019-11-13","kind":"exercise","acquired":false,"shares":8530145,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Quaker Bioventures II, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"Reflects 1-for-24.69 reverse stock split which became effective on October 28, 2019."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for the purposes of Section 16 or otherwise."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":345489},"source":{"system":"sec-edgar","filing":"0001192482-19-000420","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1339379/000119248219000420/edgar.xml","form_type":"4"}},{"id":3372627,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":148623,"kind":"person","name":"Oliva Adele C","position":1,"cik":"0001339379","reported_name":"Oliva Adele C","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-11-13T20:48:29.000Z","date":"2019-11-13","kind":"exercise","acquired":true,"shares":516947,"ownership":{"direct":false,"nature":"By Quaker Bioventures II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for the purposes of Section 16 or otherwise."}],"balance_after":1751100,"source":{"system":"sec-edgar","filing":"0001192482-19-000420","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1339379/000119248219000420/edgar.xml","form_type":"4"}},{"id":3372626,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":148623,"kind":"person","name":"Oliva Adele C","position":1,"cik":"0001339379","reported_name":"Oliva Adele C","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-11-13T20:48:29.000Z","date":"2019-11-13","kind":"exercise","acquired":true,"shares":345489,"ownership":{"direct":false,"nature":"By Quaker Bioventures II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for the purposes of Section 16 or otherwise."}],"balance_after":1234153,"source":{"system":"sec-edgar","filing":"0001192482-19-000420","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1339379/000119248219000420/edgar.xml","form_type":"4"}},{"id":3372625,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":148623,"kind":"person","name":"Oliva Adele C","position":1,"cik":"0001339379","reported_name":"Oliva Adele C","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-11-13T20:48:29.000Z","date":"2019-11-08","kind":"purchase","acquired":true,"shares":153846,"price":13,"value":1999998.0,"ownership":{"direct":false,"nature":"By Quaker Bioventures II, L.P."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects 705,530 shares of common stock received as a payment-in-kind dividend on Series A Preferred Stock and Series B Preferred Stock exempt from reporting under Rule 16a-9(a)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for the purposes of Section 16 or otherwise."}],"balance_after":888664,"source":{"system":"sec-edgar","filing":"0001192482-19-000420","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339379/000119248219000420/edgar.xml","form_type":"4"}}]}